No Data
Congenital Adrenal Hyperplasia Landscape Research 2024: Comprehensive Insights About 8+ Pipeline Drugs Featuring Neurocrine Biosciences, Spruce Biosciences, Lundbeck, and HBM Alpha Therapeutics
Stifel Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $166
Neurocrine Biosciences To Present At Jefferies London Healthcare Conference; Webcast At 8:30 AM ET
Neurocrine Biosciences To Present At Stifel Healthcare Conference; Webcast At 10:55 AM ET
US Manufacturing Index Rises To 43, Highest Since 2020
Piper Sandler Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $160
No Data
No Data
